Market Cap | 56.06M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -898.39M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 1.00% |
Sales | 58.89M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -89.00% |
Dividend | N/A | Price/Book | 0.10 | EPS next 5Y | - | 52W High Chg | -95.00% |
Recommedations | - | Quick Ratio | 1.72 | Shares Outstanding | 5.12M | 52W Low Chg | 30.00% |
Insider Own | 55.09% | ROA | -414.97% | Shares Float | 2.30M | Beta | 1.92 |
Inst Own | 0.31% | ROE | -1,160.63% | Shares Shorted/Prior | 52.04K/5.91K | Price | 0.55 |
Gross Margin | 32.64% | Profit Margin | - | Avg. Volume | 271,277 | Target Price | - |
Oper. Margin | -78.86% | Earnings Date | - | Volume | 100,732 | Change | -3.35% |
ETAO International Co., Ltd., a digital healthcare company, provides medical care services. It develops healthcare ecosystem that consist online telemedicine, artificial intelligence, big data evaluation, online insurance, pharmacy, biotech, offline hospitals, and specialty clinics services. The company was incorporated in 2020 and is based in New York, New York.